BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 36294760)

  • 1. A Personalized Longitudinal Strategy in Low-Grade Glioma Patients: Predicting Oncological and Neural Interindividual Variability and Its Changes over Years to Think One Step Ahead.
    Duffau H
    J Pers Med; 2022 Oct; 12(10):. PubMed ID: 36294760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated Awake Surgical Resection(s) for Recurrent Diffuse Low-Grade Gliomas: Why, When, and How to Reoperate?
    Duffau H
    Front Oncol; 2022; 12():947933. PubMed ID: 35865482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncological and functional neurosurgery: Perspectives for the decade regarding diffuse gliomas.
    Duffau H
    Rev Neurol (Paris); 2023 Jun; 179(5):437-448. PubMed ID: 36907710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain connectomics applied to oncological neuroscience: from a traditional surgical strategy focusing on glioma topography to a meta-network approach.
    Duffau H
    Acta Neurochir (Wien); 2021 Apr; 163(4):905-917. PubMed ID: 33564906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic Interplay between Lower-Grade Glioma Instability and Brain Metaplasticity: Proposal of an Original Model to Guide the Therapeutic Strategy.
    Duffau H
    Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The challenge to remove diffuse low-grade gliomas while preserving brain functions.
    Duffau H
    Acta Neurochir (Wien); 2012 Apr; 154(4):569-74. PubMed ID: 22278663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxes of evidence-based medicine in lower-grade glioma: To treat the tumor or the patient?
    Duffau H
    Neurology; 2018 Oct; 91(14):657-662. PubMed ID: 30158156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a risk of seizures in "preventive" awake surgery for incidental diffuse low-grade gliomas?
    Lima GL; Duffau H
    J Neurosurg; 2015 Jun; 122(6):1397-405. PubMed ID: 25723301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute progression of untreated incidental WHO Grade II glioma to glioblastoma in an asymptomatic patient.
    Cochereau J; Herbet G; Rigau V; Duffau H
    J Neurosurg; 2016 Jan; 124(1):141-5. PubMed ID: 26162036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse low-grade glioma, oncological outcome and quality of life: a surgical perspective.
    Duffau H
    Curr Opin Oncol; 2018 Nov; 30(6):383-389. PubMed ID: 30124519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Legal, Cultural, and Socioeconomic Parameters in Low-Grade Glioma Management: Variability Across Countries and Implications for Awake Surgery.
    Vanacôr C; Duffau H
    World Neurosurg; 2018 Dec; 120():47-53. PubMed ID: 30170145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional Mapping before and after Low-Grade Glioma Surgery: A New Way to Decipher Various Spatiotemporal Patterns of Individual Neuroplastic Potential in Brain Tumor Patients.
    Duffau H
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32933174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proposal of screening for diffuse low-grade gliomas in the population from 20 to 40years].
    Mandonnet E; Taillandier L; Duffau H
    Presse Med; 2017 Oct; 46(10):911-920. PubMed ID: 28927746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New concepts in surgery of WHO grade II gliomas: functional brain mapping, connectionism and plasticity--a review.
    Duffau H
    J Neurooncol; 2006 Aug; 79(1):77-115. PubMed ID: 16607477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White Matter Tracts and Diffuse Lower-Grade Gliomas: The Pivotal Role of Myelin Plasticity in the Tumor Pathogenesis, Infiltration Patterns, Functional Consequences and Therapeutic Management.
    Duffau H
    Front Oncol; 2022; 12():855587. PubMed ID: 35311104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Awake surgery for WHO Grade II gliomas within "noneloquent" areas in the left dominant hemisphere: toward a "supratotal" resection. Clinical article.
    Yordanova YN; Moritz-Gasser S; Duffau H
    J Neurosurg; 2011 Aug; 115(2):232-9. PubMed ID: 21548750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain Plasticity Profiling as a Key Support to Therapeutic Decision-Making in Low-Grade Glioma Oncological Strategies.
    Ng S; Duffau H
    Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updated perspectives on awake neurosurgery with cognitive and emotional assessment for patients with low-grade gliomas.
    Duffau H
    Expert Rev Neurother; 2021 Apr; 21(4):463-473. PubMed ID: 33724148
    [No Abstract]   [Full Text] [Related]  

  • 19. Identifying clinical risk in low grade gliomas and appropriate treatment strategies, with special emphasis on the role of surgery.
    Boissonneau S; Duffau H
    Expert Rev Anticancer Ther; 2017 Aug; 17(8):703-716. PubMed ID: 28608763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The persistent crucial role of the left hemisphere for language in left-handers with a left low grade glioma: a stimulation mapping study.
    Matsuda R; Moritz-Gasser S; Duvaux S; Fernández Coello A; Martinoni M; Duffau H
    Acta Neurochir (Wien); 2014 Apr; 156(4):661-70; discussion 670. PubMed ID: 24452594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.